Back to search results

Collecting Data on Childhood Cancer Patients at St. Jude

This study is collecting information on children and young adults who have been treated for childhood cancer at St. Jude Children's Research Hospital. It's an observational study, meaning researchers are watching and recording information rather than testing a new treatment. The goal is to understand the long-term health and any side effects (late toxicities) that can happen after cancer treatment. Researchers will collect data on patients currently being treated, those who have finished treatment, and participants in the St. Jude Alumni and St. Life programs. They will follow these patients for 25 years to see how they are doing. Anyone who is a St. Jude patient actively being followed or treated for childhood cancer can join.

Study design
This is an observational study designed to collect data on up to 30,000 participants. It is not testing a new treatment but rather gathering information over time.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 25 years to review outcomes and late toxicities.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT00684580

Protocol For Collecting Data On Patients With Childhood Cancer

Recruiting
Not specifiedAll AgesObservational
St. Jude Children's Research Hospital
~30,000 participants
Updated 2026-06-17 on ClinicalTrials.gov
What's tested:Data Collection

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
To provide continuing review of outcome and late toxicity for all patients actively being followed or treated for childhood cancer at St. Jude Children's Research Hospital, all St Jude Alumni and all St. Life participants.
Measured over 25 years

Conditions

Childhood Cancer

Explore related trials

Childhood Malignant Neoplasm

Where it's being run

1 sites across 1 states
Tennessee1

Study leadership

  • Melissa M Hudson, MD · PRINCIPAL_INVESTIGATOR · St. Jude Children's Research Hospital

Who to contact

Melissa M Hudson, MD
[email protected]
888-226-4343
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

All St Jude patients actively being followed or treated for childhood cancer

Exclusion

St. Jude consult only patients
St. Jude patients permanently discharged from care and follow-up Permanently discharged patients include patients who have electively transferred their oncologic care to another institution, those who are noncompliant with recommended follow-up or those leaving the institution against medical advice.
Patients referred to St. Jude for limited care on phase 1 protocol.

What this trial measures

  • To provide continuing review of outcome and late toxicity for all patients actively being followed or treated for childhood cancer at St. Jude Children's Research Hospital, all St Jude Alumni and all St. Life participants.25 years